A state-of-the-art review of the management and treatment of taste and smell alterations in adult oncology patients

Supportive Care in Cancer

Volumn 23, Issue 9, 2015, Pages 2843-2851

  Thorne, Trina ^a,b   Olson, Karin ^a   Wismer, Wendy ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Department of Agriculture Food and Nutritional Science University of Alberta ^*  (Canada)

Author keywords

Cancer; Chemosensory; Dysgeusia; Neoplasm; Smell; Taste

Indexed keywords

AMIFOSTINE; BETHANECHOL; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRONABINOL; GLUTAMINE; MEGESTROL ACETATE; ZINC SULFATE;

BREAST CANCER; CANCER PATIENT; CINAHL; DIET; DYSGEUSIA; FLAVOR; HUMAN; LUNG CANCER; LYMPHOMA; MEDLINE; MIRACLE FRUIT; ODOR; OVARY CANCER; PATIENT COUNSELING; PRIORITY JOURNAL; REVIEW; SCOPE OF PRACTICE; SELF CARE; SMELLING DISORDER; SUPPLEMENTATION; TASTE; TASTE DISORDER; ADULT; COMPLICATION; DISEASE MANAGEMENT; NEOPLASM; OLFACTION DISORDERS; PHYSIOLOGY;

ADULT; DISEASE MANAGEMENT; DYSGEUSIA; HUMANS; NEOPLASMS; OLFACTION DISORDERS; SMELL; TASTE; ZINC SULFATE;

EID: 84938349673     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-015-2827-1     Document Type: Review

References (25)

1. McLaughlin L, Mahon SM (2012) Understanding taste dysfunction in patients with cancer. Clin J Oncol Nurs 16(2):171–178
2. Ravasco P (2005) Aspects of taste and compliance in patients with cancer. Eur J Oncol Nurs 9:S84–S91
3. Hovan AJ, Williams MP, Stevenson-Moore P, et al (2010) A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 18:1081–1087
4. Hutton JL, Baracos VE, Wismer WV (2007) Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer. J Pain Symptom Manag 33(2):156–165
5. Yakirevitch A, Bercovici M, Migirov L, et al (2006) Olfactory function in oncologic hospice patients. J Palliat Med 9(1):57–60
6. Mahmoud FA, Aktas A, Walsh D, et al (2011) A pilot study of taste changes among hospice inpatients with advanced cancer. Am J Hosp Palliat Med 28(7):487–492
7. Zabernigg A, Gamper E, Giesinger JM, et al (2010) Taste alterations in cancer patients receiving chemotherapy: a neglected side effect? Oncologist 15(8):913–920
8. Grant MJ, Booth A (2009) A typology of reviews: an analysis of 14 review types and associated methodologies. Health Inf Libr J 26:91–108
9. Brisbois TD, de Kock IH, Watanabe SM, et al (2011) Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double blind, placebo-controlled pilot trial. Ann Oncol 22:2086–2093
10. Lyckholm L, Heddinger SP, Parker G, et al (2012) A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders. J Pain Palliat Care Pharmacother 26(2):111–114
11. Rehwaldt M, Wickham R, Purl S, et al (2009) Self-care strategies to cope with taste changes after chemotherapy. Oncol Nurs Forum 36(2):E47–E56
12. Ripamonti C, Zecca E, Brunelli C, et al (1998) A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer 82(10):1938–1945
13. Schiffman SS, Sattely-Miller EA, Taylor EL, et al (2007) Combination of flavor enhancement and chemosensory education improves nutritional status in older cancer patients. J Nutr Health Aging 11(5):439–454
14. Wilken MK, Satiroff BA (2012) Pilot study of “miracle fruit” to improve food palatability for patients receiving chemotherapy. Clin J Oncol Nurs 16(5):E173–E177
15. Buntzel J, Glatzel M, Mucke R, et al (2007) Influence of amifostine on late radiation-toxicity in head and neck cancer: a follow up study. Anticancer Res 27:1953–1956
16. Jham BC, Chen H, Carvalho AL, et al (2009) A randomized phase III prospective trial of bethanechol to prevent mucositis, candidiasis, and taste loss in patients with head and neck cancer undergoing radiotherapy: a secondary analysis. J Oral Sci 51(4):565–572
17. Strasser F, Demmer R, Böhme C, et al (2008) Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine: a randomized, placebo-controlled, double blind study. Oncologist 13(3):337–346
18. Yamagata T, Nakamura Y, Yamagata Y, et al (2003) The pilot trial of the prevention of the increase in electrical taste thresholds by zinc containing fluid infusion during chemotherapy to treat primary lung cancer. J Exp Clin Cancer Res 22(4):557–563
19. Erkurt E, Erkisi M, Tunali C (2000) Supportive treatment in weight-losing cancer patients due to the additive adverse effects of radiation treatment and/or chemotherapy. J Exp Clin Cancer Res 19(4):431–439
20. Halyard MY et al (2007) Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys 67(5):1318–1322
21. Teulings FA, van Gilse HA, Henkelman MS, et al (1980) Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer. Cancer Res 40(7):2557–2561
22. Kouvaris JR, Kouloulias VE, Vlahos LJ (2007) Amifostine: the first selective-target and broad-spectrum radioprotector. Oncologist 12(6):738–747
23. Hong JH, Omur-Ozbek P, Stanek BT, et al (2009) Taste and odor abnormalities in cancer patients. J Support Oncol 7(2):58–65
24. Epstein JB, Thariat J, Bensadoun RJ, et al (2012) Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin 62(6):400–422
25. Lawless HT, Heymann H (2010) Sensory evaluation of food: principles and practices, 2nd edn. Chapman & Hall, New York, p. 596